Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.

Marking World Cancer Day 2025, this week's Executive Q&A is with Diego Santoro, General Manager & Head of International ...

Background: The use of T cells expressing chimeric antigen receptor (CAR T) engineered to target CD19 constitutes breakthrough treatment for relapsed or refractory B cell non-Hodgkin lymphoma (R/R ...

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma ...

Although CAR T cell therapy for B cell-driven refractory autoimmune diseases is still in its infancy, these early clinical results show promises for patients. Therefore, it is likely that CAR T cell ...

Judy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy ... an uneducated opinion” Since my experience as a patient, I have become more involved ...